Palido-OD 3 Tablet ER
Marketer
Torrent Pharmaceuticals Ltd
Salt Composition
Paliperidone (3mg)
Overview Palido-OD 3 Tablet ER
Palido-OD 3 Extended-Release tablets treat schizophrenia (a mental illness causing hallucinations, delusions, and impaired thinking/behavior) and mania. Palido-OD 3 ER can be taken with or without food, but consistent daily timing ensures stable blood levels. Follow your doctor's prescribed dosage and duration; if a dose is missed, take it immediately upon recall. Abrupt cessation is unsafe and may exacerbate symptoms; consult your physician before stopping. Immediately discontinue use if Neuroleptic Malignant Syndrome (NMS) occurs (fever, muscle stiffness, altered awareness). Common side effects include involuntary eye movements (nystagmus), tremors, dizziness, and drowsiness; avoid driving or tasks requiring alertness until effects are known. Increased diabetes risk is possible; regular glucose monitoring is recommended. Report any unusual mood or behavioral shifts, new or worsening depression, or suicidal ideation to your doctor immediately.
Uses of Palido-OD 3 Tablet ER
Psychotic disorders encompassing schizophrenia and manic episodes.
Major Benefits of Palido-OD 3 Tablet ER:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Palido-OD 3 Tablet ER can be consumed with or without food, though consistent daily timing is recommended.
Common Side effects of Palido-OD 3 Tablet ER:
- Abnormal involuntary movements
- Dizziness
- Nystagmus (involuntary eye movement)
- Sleepiness
- Tremors
How to use Palido-OD 3 Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for Palido-OD 3 Tablet ER. Ingest the tablet whole; do not fracture, chew, or crush it. While you can consume it with or without food, consistent timing is recommended.
How Palido-OD 3 Tablet ER works:
Palido-OD 3 Extended-Release tablets are classified as an atypical antipsychotic medication. Their mechanism of action involves modulating neurotransmitter levels, specifically dopamine and serotonin, to positively influence mood, cognitive function, and behavior.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Palido-OD 3 Extended-Release tablets and alcohol can result in pronounced somnolence.
PregnancyCONSULT YOUR DOCTOR
The extended-release Palido-OD 3 Tablet carries a potential risk during pregnancy. While human data is scarce, animal research indicates possible harm to the fetus. A physician will assess the relative benefits and risks prior to prescribing this medication. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Palido-OD 3 tablets likely pose a risk during lactation. Available human data indicate potential transfer to breast milk, possibly harming the infant.
DrivingUNSAFE
Taking Palido-OD 3 Extended-Release tablets could reduce alertness, impair vision, or cause drowsiness and dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Exercise caution when administering Palido-OD 3 Tablet ER to individuals with impaired renal function; dosage modification may be necessary. Physician consultation is advised. Palido-OD 3 Tablet ER is contraindicated in patients experiencing end-stage renal disease.
LiverCAUTION
Exercise caution when administering Palido-OD 3 Tablet ER to individuals with severe hepatic impairment; dosage modification may be necessary. Consult a physician. Data regarding Palido-OD 3 Tablet ER use in such patients is limited. Dosage alteration is not advised for those with mild to moderate liver dysfunction.
What if you forget to take Palido-OD 3 Tablet ER :
NA
Facts to Know About Palido-OD 3 Tablet ER
| Label | Value |
|---|---|
| Chemical Category | Benzisoxazole compound |
| Developing Habits | No. |
| Treatment Category | Neuroscience Central Nervous System |
| Action Class | Novel Antipsychotics |
3,018 People bought this recently